Form 4: Bio-Rad Laboratories President Receives Stock Grant
Insider Transaction (Form 4)
Eva Anette Engelhardt, EVP, President, CDG of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Option exercise/conversion: acquired 1,027 Bio-Rad A Common Stock on September 5, 2026; holds 1,530 after (Direct).
- Tax/exercise-price withholding: disposed of 369 Bio-Rad A Common Stock at $386.11 ($142,475) on September 5, 2026; holds 1,161 after (Direct).
- Option exercise/conversion: acquired 1,152 Bio-Rad A Common Stock on September 6, 2026; holds 2,313 after (Direct).
- Tax/exercise-price withholding: disposed of 485 Bio-Rad A Common Stock at $386.11 ($187,263) on September 6, 2026; holds 1,828 after (Direct).
- Grant/award: acquired 4,313 Restricted Stock Units on September 4, 2026; holds 4,313 after (Direct).
- Option exercise/conversion: disposed of 1,027 Restricted Stock Units on September 5, 2026; holds 3,083 after (Direct).
- Option exercise/conversion: disposed of 1,152 Restricted Stock Units on September 6, 2026; holds 2,304 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Eva Anette Engelhardt — Officer (EVP, President, CDG)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 1,027 | — | — | 1,530 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 369 | $386 | $142.5K | 1,161 |
| 2026-09-06 | Option exercise/conversion | Bio-Rad A Common Stock | 1,152 | — | — | 2,313 |
| 2026-09-06 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 485 | $386 | $187.3K | 1,828 |
| 2026-09-04 | Grant/award | Restricted Stock Units | 4,313 | — | — | 4,313 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 1,027 | — | — | 3,083 |
| 2026-09-06 | Option exercise/conversion | Restricted Stock Units | 1,152 | — | — | 2,304 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Option exercise/conversion (1,027 shares) |
| 2026-09-05 | Tax/exercise-price withholding (369 shares) |
| 2026-09-06 | Option exercise/conversion (1,152 shares) |
| 2026-09-06 | Tax/exercise-price withholding (485 shares) |
| 2026-09-04 | Grant/award (4,313 shares) |
| 2026-09-05 | Option exercise/conversion (1,027 shares) |
| 2026-09-06 | Option exercise/conversion (1,152 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Eva Anette Engelhardt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.